Objective: To highlight diagnostic and therapeutic issues about Rathke cleft cysts for otorhinolaryngologists. Study Design: Retrospective. Methods: We retrospectively reviewed data collected on Rathke cleft cysts between 1978 and 1998: presenting symptoms, visual acuity, surgical treatment, complications, recurrences, and effect on daily activity. Results: Twenty-nine patients were diagnosed with a Rathke cleft cyst (11 male and 18 female patients; mean age, 46 y). The most common presenting symptom was head pain (55%). The majority (59%) of cases demonstrated suprasellar extension on preoperative imaging, with pituitary dysfunction identified in 66%. Recurrence occurred in eight patients (28%). Postoperative visual function improved or remained stable in all patients. Persistent pituitary dysfunction required hormonal supplementation in seven patients (24%). Only one patient with an astrocytoma in addition to a Rathke cleft cyst did not maintain the ability to perform normally on an assessment of activities of daily living, a striking contrast to patients with craniopharyngioma. Conclusions: Conclusions were as follows: 1) Rathke cleft cysts must be considered as sources of head pain and pituitary dysfunction. 2) Persistent or recurrent cyst formation occurs in approximately one-third of the patients. Recurrence may take many years, and follow-up imaging is recommended for at least a decade. 3) Maintenance of the ability to perform the activities of normal daily living can be expected after surgical management. 4) Most Rathke cleft cysts can be managed through transnasal exposure of the sella. 5) Packing the sella may result in predisposition to recurrent cyst formation.
INTRODUCTION
Understanding the presentation, treatment, and outcome in patients with Rathke cleft cysts is useful for otorhinolaryngologists, especially those involved in the care of patients with pituitary lesions. Identification and characterization of cystic pituitary lesions are aided by the increasing resolution of modern imaging modalities. 1, 2 Rathke cleft cysts are the most likely common incidental pituitary lesion, as was noted in 33% of unselected autopsy specimens, 3 but little information related to the clinical management of this entity is available. The present review of surgically treated Rathke cleft cysts was undertaken to further characterize the management and outcome of this clinical entity.
MATERIALS AND METHODS
The medical records were reviewed of patients who underwent surgical treatment of a Rathke cleft cyst during the years 1978 -1998. The present study was approved by the Institutional Review Board of the Mayo Clinic, Rochester, MN. Data collected included demographic data (sex and age), presenting symptoms, nasal symptoms, and pituitary function. Also recorded were the surgical approach, hospital stay, complications, and cyst recurrence. The effect of the cyst on daily living was assessed by using the Katz scale. 4 The Katz scale is an index of independent daily living that evaluates an individual's dependence or independence with bathing, dressing, going to the toilet, transfer, continence, and feeding. Patients who are independent in all of the preceding activities are scored as A. Patients who are dependent in all six functions are scored as G, with B to F representing various degrees of dependence. All patients studied consented to chart review and, in addition, were contacted by telephone for current follow-up.
RESULTS
Twenty-nine patients underwent surgical treatment of a Rathke cleft cyst between 1978 and 1998. This included 11 male and 18 female patients with an age range of 14.6 to 72.6 years at diagnosis (median age, 45.1 y; mean age, 46.0 y). Follow-up ranged from 6 days to 21.5 years, with a mean follow-up of 6.6 years and a median follow-up of 5.9 years. Table I lists the presenting symptoms and percentages of patients with those symptoms.
Nasal symptoms noted preoperatively were uncommon and included one patient with a history of recurrent sinusitis and one patient with allergic rhinitis. Postoperative nasal symptoms noted by nine patients included obstruction (two patients), drainage (four patients), recur- Postoperatively, 22 patients (76%) did not require pituitary hormone replacement therapy at last follow-up. The replacement therapy in the remaining seven patients is presented in Table III .
Before 1987, patients were evaluated with only computed tomography (CT) scans (21%). Subsequently, most patients (41%) had both CT and magnetic resonance imaging (MRI) evaluations. Thirty-five percent of patients underwent only MRI, and one patient had imaging with CT and magnetic resonance angiography. Cyst location was intrasellar alone in 12 cases (41%); 17 cases (59%) involved intrasellar and suprasellar sites. Figure 1 is a representative MRI scan from a patient.
Initial treatment for the lesions involved a transseptal, trans-sphenoidal approach to the sella in 26 cases (90%) and an endoscopic transnasal approach to the sella in 1 case (3%). A craniotomy was the first treatment in two patients (7%). One of these patients was thought to have a third recurrence of a craniopharyngioma, and the other was thought to have an arachnoid cyst. The sella was packed in 22 cases (76%) and was left unpacked in the remainder. The material used for packing is listed in Table IV .
Recurrence was noted in eight patients (28%) at 2 months to 10.5 years after initial treatment. Five patients have been monitored with serial MRI scans without further operation. Further surgical procedures were completed in three patients: two endoscopic transnasal approaches and one craniotomy. Seven of the eight patients in whom a recurrent cyst developed had the sella packed. One patient had a second recurrence, which has been monitored without further operation.
A cerebrospinal fluid (CSF) leak was noted intraoperatively in seven patients. This did not appear to be associated with cyst recurrence because 6 of 22 patients (27%) without a leak had a recurrent cyst develop whereas 2 of 7 patients (29%) with a CSF leak noted intraopera- tively had a cyst recurrence. Postoperative CSF leaks did not occur. Visual function was normal preoperatively in 20 patients and remained normal in this group. Nine patients had visual deficits identified preoperatively. Six patients were noted to have bitemporal hemianopsia. Five of these six patients had return of normal vision postoperatively. The remaining patient had improvement. One patient noted a left-side visual field deficit, which returned to normal postoperatively. Two patients had pre-existing visual deficits unrelated to the pituitary cyst and did not have a change in vision.
When patients' preoperative and postoperative Katz scale scores were compared, only one patient noted a decrease from a D to a G. This patient had an underlying tumor of the brain parenchyma in addition to her pituitary lesion. The remainder rated a score of A both preoperatively and postoperatively.
When attempts were made to contact patients by telephone, four patients were lost to follow-up. Six had died since the last clinical visit. Two patients noted recurrent sinusitis, one patient noted a change in the external appearance of the nose, and six patients described nasal drainage or obstruction. The majority of patients' preoperative symptoms resolved after operation. These data are presented in Table V .
DISCUSSION
The pituitary gland begins to develop at approximately 24 days in the embryo. It originates as ectoderm from the stomodeum anterior to the oropharyngeal membrane and neuroectoderm of the diencephalon. A diverticulum of the oral ectoderm grows toward the midbrain to form a pouch. The stalk of the pouch regresses, isolating the ectodermally lined cyst from the oral cavity. Growth of the ectoderm in the anterior portion forms the anterior lobe (pars distalis) of the pituitary and typically reduces the lumen of the cavity to a narrow residual cleft. The posterior wall of a Rathke pouch typically does not proliferate and is thought to give rise to the thin pars intermedia. 5 It is generally thought that persistence and enlargement of the residual cleft are responsible for the formation of Rathke cleft cysts. Other explanations have suggested that the origin may be neuroepithelial cells, 6 metaplastic anterior pituitary cells, 7 or endodermal cells. 8 The differential diagnosis of cystic lesions in the sella includes cystic craniopharyngiomas, cystic or hemorrhagic pituitary adenomas, arachnoid cysts, and pars intermedia cysts. Computed tomography and MRI may aid in the diagnosis by characterizing the site of the cyst relative to the gland, the presence or absence of calcification in the cyst wall, and cyst wall enhancement.
1,2 However, the enhancement of the cyst contents in Rathke cleft cysts is variable and not diagnostic.
Local mass effect is the most common cause of symptoms, potentially resulting in headache, visual symptoms attributable to compression of the optic nerves, anterior pituitary dysfunction, and hyperprolactinemia attributable to compression of the pituitary stalk. 9 Cyst inflammation may result in increased mass effect, tissue destruction, aseptic meningitis, and abscess formation. 10, 11 Most patients in the present study had resolution of symptoms as a consequence of the operation (Tables III-V) , with few complications.
Daily living activity maintained by the patients was documented in all but one patient as independent and without limitations. The one patient who was more dependent had a pre-existing tumor of the brain parenchyma and progressed from a D to a G level of function. In contrast, patients who have craniopharyngiomas consistently have significant functional limitation. 12 The trans-septal, trans-sphenoidal approach to the sella was used primarily during the period of the present study and resulted in few complications. Currently, an endoscopic transnasal approach is favored and virtually eliminates potential cosmetic nasal change, as noted by one patient. The endoscopic approach has proven efficacy in the treatment of most pituitary tumors as well. 13, 14 Recurrent cysts developed in eight patients, seven of whom had undergone packing of the sella. Packing of the sella is commonly used for large cysts as a chiasmapexy and in the event of a CSF leak during the procedure. Packing the sella was common in the present series (22 of 29 patients). The primary cause of recurrent Rathke cleft cyst formation is residual secretory epithelium lacking communication to the sphenoid sinus. Large cyst size and suprasellar extension increase the probability of incomplete cyst removal. Because 88% of the cyst recurrences had packing placed in the sella, it seems plausible that packing may inhibit residual epithelium from draining into the sphenoid sinus and thereby promote recurrence. Clearly, indications for packing do exist and include chiasmal support (chiasmapexy) and CSF leaks. The authors 15 who reported on their experience with 43 patients. Nearly all of the rest of the literature available on this subject comprises case reports. Important aspects relevant to the otorhinolaryngologist, which are supported by the present study, include the frequent presentation with headaches, a common symptom in an otorhinolaryngologic practice; the high percentage of successful symptom resolution and low complication rate with surgical management of these lesions; and the excellent expected long-term functional outcome.
CONCLUSION
1. Rathke cleft cysts must be considered as sources of head pain and pituitary dysfunction.
2. Persistent or recurrent cyst formation occurs in approximately one-third of the patients. Recurrence may take many years, and follow-up imaging is recommended for at least a decade.
3. Maintenance of the ability to perform the activities of normal daily living can be expected after surgical management.
4. Most Rathke cleft cysts can be managed through transnasal exposure of the sella.
5. Packing the sella may predispose to recurrent cyst formation.
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